KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLoansLoans - NetNon-Current DebtOther Non-Current AssetsPayablesPreferred SharesRetained EarningsSecurities - Held-to-maturitySecurities - TradableSecurities BorrowedSecurities BoughtShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morgan Stanley (MS) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Morgan Stanley (MS) over the last 12 years, with Sep 2025 value amounting to $103.7 billion.

  • Morgan Stanley's Cash & Equivalents rose 13.89% to $103.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $103.7 billion, marking a year-over-year increase of 13.89%. This contributed to the annual value of $105.4 billion for FY2024, which is 18.10% up from last year.
  • Latest data reveals that Morgan Stanley reported Cash & Equivalents of $103.7 billion as of Q3 2025, which was down 4.94% from $109.1 billion recorded in Q2 2025.
  • In the past 5 years, Morgan Stanley's Cash & Equivalents ranged from a high of $136.1 billion in Q1 2022 and a low of $89.2 billion during Q4 2023.
  • Over the past 3 years, Morgan Stanley's median Cash & Equivalents value was $103.7 billion (recorded in 2025), while the average stood at $100.6 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 30.70% in 2021, then slumped by 30.36% in 2023.
  • Quarterly analysis of 5 years shows Morgan Stanley's Cash & Equivalents stood at $127.7 billion in 2021, then climbed by 0.31% to $128.1 billion in 2022, then tumbled by 30.36% to $89.2 billion in 2023, then grew by 18.10% to $105.4 billion in 2024, then grew by 13.89% to $103.7 billion in 2025.
  • Its Cash & Equivalents stands at $103.7 billion for Q3 2025, versus $109.1 billion for Q2 2025 and $90.7 billion for Q1 2025.